Bristol-Myers Squibb Co (BMY)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

430 E. 29TH STREET NEW YORK, NY 10016

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Data as of 2021-10-09 09:00:08 -0400
Market Cap127.238 Billion Shares Outstanding2.222 Billion Avg 30-day Volume11.849 Million
P/E Ratio-25.05183 Dividend Yield3.383 EPS-2.25
Price/Sales2.98 Debt to Equity3.01 EBITDA14.153 Billion
Price to Book Value3.59 Forward PE7.95 Enterprise Value164.426 Billion
Total Cash12.97 Billion Current Debt18.991 Billion Gross Profit33.679 Billion
BETA0.6072 52-week High/Low69.19 / 55.01 Next Earnings Date2021-10-27 Price to Cash FLow (P/CF) 37.8927
Data provided by IEX Cloud
View SEC Filings from BMY instead.

View recent insider trading info

Funds Holding BMY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BMY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

25 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STORCH GERALD L

  • Director
65,780 2021-09-30 5

YALE PHYLLIS R

  • Director
10,622 2021-09-30 5

ARDUINI PETER J

  • Director
33,648 2021-09-30 5

RICE DERICA W

  • Director
6,618 2021-09-30 5

PRICE PAULA A

  • Director
4,973 2021-09-30 5

HALLER JULIA A

  • Director
10,870 2021-09-30 7

SAMUELS THEODORE R. II

  • Director
26,969 2021-09-30 5

HIDALGO MEDINA MANUEL

  • Director
2,116 2021-09-30 4

CAFORIO GIOVANNI BOARD CHAIR AND CEO

  • Officer
  • Director
483,980 2021-09-20 5

ELKINS DAVID V EVP, CHIEF FINANCIAL OFFICER

  • Officer
203,483 2021-08-12 6

POWELL ANN EVP, CHIEF HUMAN RESOURCES

  • Officer
47,613 2021-08-03 2

LEUNG SANDRA EVP, GENERAL COUNSEL

  • Officer
430,266 2021-07-30 3

VON AUTENRIED PAUL EVP, CHIEF INFORMATION OFFICER

  • Officer
114,670 2021-07-30 4

VESSEY RUPERT EVP, RESEARCH & EARLY DEV.

  • Officer
68,062 2021-07-30 11

DUBOW ADAM SVP,CHIEFCOMPLIANCE&ETHICSOFF.

  • Officer
14,749 2021-07-30 4

SANTIAGO KAREN MURPHY SVP & CONTROLLER

  • Officer
16,637 2021-07-01 2

HIRAWAT SAMIT EVP,CHIEF MED.OFFR.,DRUG DEV.

  • Officer
30,465 2021-07-01 2

WEESE MICHELLE EVP, CORPORATE AFFAIRS

  • Officer
7,540 2021-07-01 2

BONNEY MICHAEL W

  • Director
9,342 2021-06-30 6

EID JOSEPH SVP,HEAD GLOB. MEDICAL AFFAIRS

  • Officer
13,794 2021-06-03 4

SCHMUKLER LOUIS S EVP,PRES.,GLOB.PROD. & SUPPLY

  • Officer
31,956 2021-05-10 2

MILY ELIZABETH EVP, STRATEGY & BD

  • Officer
23,282 2021-04-01 2

BERTOLINI ROBERT J

  • Director
26,648 2021-03-31 3

EMMENS MATTHEW

  • Director
26,999 2021-03-31 3

PALIWAL DINESH C

  • Director
40,501 2021-03-31 3

BOERNER CHRISTOPHER S. EVP, CHIEF COMMERCIAL OFFICER

  • Officer
136,698 2021-03-10 2

SATO VICKI L

  • Director
0 2021-02-01 1

VOUSDEN KAREN H

  • Director
0 2021-02-01 2

AHMED NADIM EVP AND PRESIDENT, HEMATOLOGY

  • Officer
40,855 2020-12-31 3

LACY ALAN J

  • Director
0 2020-06-30 0

GROBSTEIN MICHAEL

  • Director
0 2020-06-30 0

BANCROFT CHARLES A EVP, HEAD OF INTEGRATION

  • Officer
437,534 2020-03-10 0

ELICKER JOHN E EVP, INVESTOR RELATIONS

  • Officer
70,946 2020-03-10 0

METCALFE KATHRYN EVP, CORPORATE AFFAIRS

  • Officer
0 2020-03-10 0

BIONDI PAUL SVP, HEAD OF STRATEGY & BD

  • Officer
6,214 2019-10-02 0

LYNCH THOMAS J. JR. EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
22,223 2019-04-03 0

STORCH GERALD L

STORCH GERALD L

  • Director
0 2018-09-30 5

BASELGA JOSE

  • Director
No longer subject to file 2018-09-30 0

GORDON MURDO EVP, CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2018-08-01 0

CALDARELLA JOSEPH C SVP & CONTROLLER

  • Officer
48,076 2017-09-06 0

NIELSEN ANNE CHIEF COMPLIANCE & ETHICS OFF

  • Officer
37,974 2017-09-03 0

ANDREOTTI LAMBERTO

  • Director
1,176,844 2017-04-06 0

CUSS FRANCIS M EVP & CSO

  • Officer
321,906 2017-03-10 0

BLIN EMMANUEL SVP, CHIEF STRATEGY OFFICER

  • Officer
20,138 2017-03-10 0

WEST TOGO D JR

  • Director
0 2017-02-01 0

GLIMCHER LAURIE H M.D.

  • Director
0 2017-02-01 0

CAMPBELL LEWIS B

  • Director
2,110 2016-03-08 0

CORNELIUS JAMES M

  • Director
79,851 2015-03-31 0

MOED SAMUEL J SVP, STRAT PLAN & ANALYSIS

  • Officer
31,615 2015-03-13 0

DANIELS BRIAN SVP GLOBAL DEV & MED AFFAIRS

  • Officer
No longer subject to file 2014-07-01 0

HELLER FRANCES K SVP, BUSINESS DEVELOPMENT

  • Officer
4,218 2014-03-10 0

SIGAL ELLIOT EVP, CSO & PRESIDENT R&D

  • Officer
  • Director
195,300 2013-06-03 0

CAZALA BEATRICE J EVP COMMERCIAL OPERATIONS

  • Officer
177,118 2013-05-31 0

FREEH LOUIS J

  • Director
0 2013-02-01 0

WILLIAMS R SANDERS

  • Director
0 2013-02-01 0

CELENTANO JOHN E SVP HR PUBLIC AFFAIRS & PHILAN

  • Officer
142,142 2012-03-06 0

LEVIN JEREMY M SVP STRAT TRANSACTIONS

  • Officer
43,689 2011-10-01 0

CARLO DE NOTARISTEFANI PRES TECH OPS & SUPP FNCTNS

  • Officer
8,432 2011-06-14 0

HOOPER ANTHONY C SVP COMOPS PRES USJAP INT

  • Officer
208,419 2011-05-13 0

JOHANSSON LEIF

  • Director
0 2011-02-01 0

ZITO ROBERT T SVP & CHIEF COMM OFFICER

  • Officer
35,469 2010-03-06 0

MCBRIDE ANTHONY A SVP HUMAN RESOURCES

  • Officer
34,292 2010-03-06 0

HUET JEAN-MARC EVP & CFO

  • Officer
25,000 2009-04-30 0

ROBINSON JAMES D III

  • Director
0 2007-12-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HIDALGO MEDINA MANUEL - Director

2021-10-01 16:31:07 -0400 2021-09-30 A 121 a 2,116 direct

STORCH GERALD L - Director

2021-10-01 16:29:22 -0400 2021-09-30 A 592 a 65,780 direct

HALLER JULIA A - Director

2021-10-01 16:31:29 -0400 2021-09-30 A 549 a 10,870 direct

YALE PHYLLIS R - Director

2021-10-01 16:29:07 -0400 2021-09-30 A 549 a 10,622 direct

PRICE PAULA A - Director

2021-10-01 16:30:44 -0400 2021-09-30 A 137 a 4,973 direct

ARDUINI PETER J - Director

2021-10-01 16:31:49 -0400 2021-09-30 A 549 a 33,648 direct

RICE DERICA W - Director

2021-10-01 16:29:53 -0400 2021-09-30 A 592 a 6,618 direct

SAMUELS THEODORE R. II - Director

2021-10-01 16:29:37 -0400 2021-09-30 A 803 a 26,969 direct

CAFORIO GIOVANNI - Director - Officer BOARD CHAIR AND CEO

2021-09-22 17:19:26 -0400 2021-09-20 S 25,000 $60.64 d 483,980 direct -0.6602 -1.5998 0.0 1 -1.5998 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 22:15:04 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 21:45:03 UTC -0.1817 0.2517 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 21:15:03 UTC -0.1817 0.2517 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 20:45:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 20:15:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 19:45:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 19:15:04 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 18:45:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 18:15:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 17:45:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 17:15:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 16:45:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 16:15:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 15:45:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 15:15:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 14:45:02 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 14:15:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 13:45:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 13:15:03 UTC -0.18 0.25 0
BRISTOL-MYERS SQUIBB CO BMY 2021-10-15 12:45:03 UTC -0.18 0.25 0

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Master Neutral Fund BMY -13.0 shares, $-783.77 2020-09-30 N-PORT
FundVantage Trust- Gotham Neutral 500 Fund BMY -42.0 shares, $-2651.46 2021-03-31 N-PORT
GMO TRUST- GMO Alternative Allocation Fund BMY -39001.0 shares, $-2563145.72 2021-05-31 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund BMY -350.0 shares, $-23387.0 2021-06-30 N-PORT
American Century Capital Portfolios, Inc.- AC Alternatives Market Neutral Value Fund BMY -6117.0 shares, $-408737.94 2021-06-30 N-PORT
GLENMEDE FUND INC- Quantitative U.S. Long/Short Equity Portfolio BMY -9340.0 shares, $-633905.8 2021-07-31 N-PORT

Elevate your investments